# Methamphetamine in the Midwestern United States: a call for advocacy and action

**Authors:** Alëna A. Balasanova, Michelle Davids

PMC · DOI: 10.3389/fpsyt.2026.1712541 · Frontiers in Psychiatry · 2026-02-19

## Full-text entities

- **Diseases:** deaths (MESH:D003643), opioid overdose (MESH:D000083682), psychosis (MESH:D011618), overdose (MESH:D062787), MUD (MESH:D000437), hepatitis C (MESH:D019698), addiction (MESH:D019966), psychiatric (MESH:D001523), opioid use disorder (MESH:D009293)
- **Chemicals:** methadone (MESH:D008691), Methamphetamine (MESH:D008694), synthetic (-), naltrexone (MESH:D009271), mirtazapine (MESH:D000078785), cocaine (MESH:D003042), naloxone (MESH:D009270), buprenorphine (MESH:D002047), bupropion (MESH:D016642), Fentanyl (MESH:D005283), amphetamine (MESH:D000661)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933426/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933426/full.md

---
Source: https://tomesphere.com/paper/PMC12933426